Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02510144 · ClinicalTrials.gov registry record · NA

Skin Prep to Reduce Postoperative Shoulder Infection

A NA study of Shoulder Infection, sponsored by University of Maryland, Baltimore.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT02510144: Completed NA study of Shoulder Infection, sponsored by University of Maryland, Baltimore.

NCT02510144 is a NA study of Shoulder Infection that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02510144, a NA study of Shoulder Infection, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

Propionibacterium acnes is the most common pathogen identified from a surgical site infection in the shoulder. Standard skin preps do not prevent this type of infection. Patients will undergo either a chlorhexidine or benzoyl peroxide prep in days leading up to surgery. Bacterial burden will be determined at the time of surgery.

Primary Outcome

Preoperative Cutibacterium acnes shoulder burden. Skin cultures of both shoulders were obtained via a detergent scrub technique the day of surgery at anterior, lateral, and posterior sites and the axilla.

Conditions Studied

Interventions

  • DRUG Skin Prep Chlorhexidine
  • DRUG Skin Prep Benzoyl Peroxide

Study Locations (1)

Maryland

  • University of Maryland Midtown Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2015-08
Est. Completion 2018-07
Phase NA
University of Maryland, Baltimore

560 total trials

What the finished NCT02510144 record still lists

NCT02510144 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Shoulder Infection appearing as the primary indexed condition, and to 2 interventions - of which Skin Prep Chlorhexidine is the first listed.

NCT02510144 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT02510144 about?

NCT02510144 is a clinical study titled "Skin Prep to Reduce Postoperative Shoulder Infection". Propionibacterium acnes is the most common pathogen identified from a surgical site infection in the shoulder. Standard skin preps do not prevent this type of infection. Patients will undergo either a chlorhexidine or benzoyl peroxide prep in days leading up to surgery. Bacterial burden will be dete...

What is the current status of trial NCT02510144?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2015-08. Estimated completion is 2018-07.

What conditions does trial NCT02510144 study?

This clinical trial studies the following conditions: Shoulder Infection.

What interventions are being tested in trial NCT02510144?

The interventions under investigation include: Skin Prep Chlorhexidine (DRUG), Skin Prep Benzoyl Peroxide (DRUG).

Who is sponsoring clinical trial NCT02510144?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02510144 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT02510144's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02510144, the US trial registry maintained by the National Library of Medicine. NCT02510144 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.